Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antipsychotic discontinuation in people with intellectual disability
NL-OMON21589Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2015
- Countries
- 1
01
Overview
Open-label, single-arm trial in intellectual disability (ID), sponsored by University Medical Center Groningen. Primary endpoint: Complete discontinuation at 16 weeks. Started Jan 2015; status: active, not recruiting.
02
Conditions
intellectual disability (ID)
Beyond the preview
Go deeper on NL-OMON21589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21589.